These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 9145895)

  • 1. Lack of ability of ciprofloxacin-rifampin prophylaxis to decrease infection-related morbidity in neutropenic patients given cytotoxic therapy and peripheral blood stem cell transplants.
    Hidalgo M; Hornedo J; Lumbreras C; Trigo JM; Gómez C; Perea S; Ruiz A; Hitt R; Cortés-Funes H
    Antimicrob Agents Chemother; 1997 May; 41(5):1175-7. PubMed ID: 9145895
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rifampin does not improve the efficacy of quinolone antibacterial prophylaxis in neutropenic cancer patients: results of a randomized clinical trial.
    Gomez-Martin C; Solá C; Hornedo J; Perea S; Lumbreras C; Valentí V; Arcediano A; Rodriguez M; Salazar R; Cortés-Funes H; Hidalgo M
    J Clin Oncol; 2000 May; 18(10):2126-34. PubMed ID: 10811678
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prophylactic antibiotics eliminate bacteremia and allow safe outpatient management following high-dose chemotherapy and autologous stem cell rescue.
    Meisenberg B; Gollard R; Brehm T; McMillan R; Miller W
    Support Care Cancer; 1996 Sep; 4(5):364-9. PubMed ID: 8883230
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sequential prophylactic oral and empiric once-daily parenteral antibiotics for neutropenia and fever after high-dose chemotherapy and autologous bone marrow support.
    Gilbert C; Meisenberg B; Vredenburgh J; Ross M; Hussein A; Perfect J; Peters WP
    J Clin Oncol; 1994 May; 12(5):1005-11. PubMed ID: 8164024
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quinolone-based antibacterial chemoprophylaxis in neutropenic patients: effect of augmented gram-positive activity on infectious morbidity. National Cancer Institute of Canada Clinical Trials Group.
    Bow EJ; Mandell LA; Louie TJ; Feld R; Palmer M; Zee B; Pater J
    Ann Intern Med; 1996 Aug; 125(3):183-90. PubMed ID: 8686975
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intensified prophylaxis of febrile neutropenia with ofloxacin plus rifampin during severe short-duration neutropenia in patients with lymphoma.
    Muñoz L; Martino R; Subirà M; Brunet S; Sureda A; Sierra J
    Leuk Lymphoma; 1999 Aug; 34(5-6):585-9. PubMed ID: 10492083
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interaction between ciprofloxacin and rifampin.
    Temple ME; Nahata MC
    Ann Pharmacother; 1999; 33(7-8):868-70. PubMed ID: 10466918
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ciprofloxacin plus piperacillin compared with tobramycin plus piperacillin as empirical therapy in febrile neutropenic patients. A randomized, double-blind trial.
    Peacock JE; Herrington DA; Wade JC; Lazarus HM; Reed MD; Sinclair JW; Haverstock DC; Kowalsky SF; Hurd DD; Cushing DA; Harman CP; Donowitz GR
    Ann Intern Med; 2002 Jul; 137(2):77-87. PubMed ID: 12118962
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Infection in patients with neutropenia that undergo an autologous peripheral blood stem cell transplant due to breast cancer].
    Palau J; Picón I; Angel Climent M; Martí R; Aznar E; Carmen Sanjuán M; Máiquez J
    Enferm Infecc Microbiol Clin; 2001 Nov; 19(9):422-7. PubMed ID: 11709119
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of rifampin for treatment of orthopedic implant-related staphylococcal infections: a randomized controlled trial. Foreign-Body Infection (FBI) Study Group.
    Zimmerli W; Widmer AF; Blatter M; Frei R; Ochsner PE
    JAMA; 1998 May; 279(19):1537-41. PubMed ID: 9605897
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Infectious complications in 126 patients treated with high-dose chemotherapy and autologous peripheral blood stem cell transplantation.
    Salazar R; Solá C; Maroto P; Tabernero JM; Brunet J; Verger G; Valentí V; Cancelas JA; Ojeda B; Mendoza L; Rodríguez M; Montesinos J; López-López JJ
    Bone Marrow Transplant; 1999 Jan; 23(1):27-33. PubMed ID: 10037047
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of two different anti-infectious approaches after high-dose chemotherapy and autologous stem cell transplantation for hematologic malignancies in a 12-year period in British Hospital, Uruguay.
    Oliver AC; Riva E; Mosquera R; Galeano S; Pierri S; Bello L; Caneiro A; Gai R; Miller A; Muxi P
    Ann Hematol; 2020 Apr; 99(4):877-884. PubMed ID: 32062742
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ceftazidime and ciprofloxacin as empiric therapy in febrile neutropenic patients undergoing hematopoietic stem cell transplantation.
    Ghazal HH; Ghazal CD; Tabbara IA
    Clin Ther; 1997; 19(3):520-6. PubMed ID: 9220216
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Empiric antimicrobial therapy of febrile neutropenic patients undergoing haematopoietic stem cell transplantation.
    Antabli BA; Bross P; Siegel RS; Small CD; Tabbara IA
    Int J Antimicrob Agents; 1999 Oct; 13(2):127-30. PubMed ID: 10595571
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prophylactic antibiotics for the prevention of neutropenic fever in patients undergoing autologous stem-cell transplantation: results of a single institution, randomized phase 2 trial.
    Eleutherakis-Papaiakovou E; Kostis E; Migkou M; Christoulas D; Terpos E; Gavriatopoulou M; Roussou M; Bournakis E; Kastritis E; Efstathiou E; Dimopoulos MA; Papadimitriou CA
    Am J Hematol; 2010 Nov; 85(11):863-7. PubMed ID: 20882526
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reappraisal with meta-analysis of the addition of Gram-positive prophylaxis to fluoroquinolone in neutropenic patients.
    Cruciani M; Malena M; Bosco O; Nardi S; Serpelloni G; Mengoli C
    J Clin Oncol; 2003 Nov; 21(22):4127-37. PubMed ID: 14615441
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reduction of chemotherapy-induced febrile leucopenia by prophylactic use of ciprofloxacin and roxithromycin in small-cell lung cancer patients: an EORTC double-blind placebo-controlled phase III study.
    Tjan-Heijnen VC; Postmus PE; Ardizzoni A; Manegold CH; Burghouts J; van Meerbeeck J; Gans S; Mollers M; Buchholz E; Biesma B; Legrand C; Debruyne C; Giaccone G;
    Ann Oncol; 2001 Oct; 12(10):1359-68. PubMed ID: 11762805
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selective bowel decontamination for the prevention of infection in acute myelogenous leukemia: a prospective randomized trial.
    Lee DG; Choi SM; Choi JH; Yoo JH; Park YH; Kim YJ; Lee S; Min CK; Kim HJ; Kim DW; Lee JW; Min WS; Shin WS; Kim CC
    Korean J Intern Med; 2002 Mar; 17(1):38-44. PubMed ID: 12014211
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevention of chemotherapy-induced febrile neutropenia by prophylactic antibiotics plus or minus granulocyte colony-stimulating factor in small-cell lung cancer: a Dutch Randomized Phase III Study.
    Timmer-Bonte JN; de Boo TM; Smit HJ; Biesma B; Wilschut FA; Cheragwandi SA; Termeer A; Hensing CA; Akkermans J; Adang EM; Bootsma GP; Tjan-Heijnen VC
    J Clin Oncol; 2005 Nov; 23(31):7974-84. PubMed ID: 16258098
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chemoprophylaxis with oral ciprofloxacin in ovarian cancer patients receiving taxol.
    Carlson JW; Fowler JM; Saltzman AK; Carter JR; Chen MD; Mitchell SK; Dunn D; Carson LF; Adcock LL; Twiggs LB
    Gynecol Oncol; 1994 Dec; 55(3 Pt 1):415-20. PubMed ID: 7530677
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.